Together, these data demonstrate that CHK1 is an essential survival factor for Burkitt lymphoma and pre-B ALL cells and that CHK1 inhibition activates BCL2-regulated and BAX/BAK-dependent apoptosis in these cells. This evidence concerns the gene BAK1 and acute lymphoblastic leukemia.